Prospective clinical evaluation of inherited retinal diseases
Not yet recruiting
- Conditions
- Inherited retinal diseases, Stargardt disease, retinal dystrophyErfelijke netvlies aandoeningen, de ziekte van Stargardt, netvliesdystrofie
- Registration Number
- NL-OMON20528
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Cohort-specific inclusion criteria:
- Clinical diagnosis of STGD and at least two pathogenic or likely pathogenic, therapy-eligible mutations in trans in the ABCA4 gene
Exclusion Criteria
- Mutations in genes that cause autosomal dominant or X-linked retinal dystrophy, or presence of biallelic mutations in autosomal recessive retinal dystrophy genes other than the gene studied in the patient cohort
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best corrected visual acuity, quantitative fundus autofluorescence intensity data, mean retinal sensitivity as measured by fundus-guided microperimetry, ellipsoid zone area as measured by SD-OCT, visual field sensitivity measured by static perimetry, macular and retinal function using multifocal and full-field ERG amplitudes and implicit time, rod and cone full-field stimulus thresholds.
- Secondary Outcome Measures
Name Time Method Quality of life and patient reported outcomes